PIRAMAL PHARMA
Back to Balance Sheet
|
PIRAMAL PHARMA Last 5 Year Total Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹3,766 Cr | ₹4,369 Cr | ₹3,851 Cr | ₹3,118 Cr | ₹2,591 Cr |
What is the latest Total Current Liabilities ratio of PIRAMAL PHARMA ?
| Year | Total Current Liabilities |
|---|---|
| Mar2025 | ₹3,766 Cr |
| Mar2024 | ₹4,369 Cr |
| Mar2023 | ₹3,851 Cr |
| Mar2022 | ₹3,118 Cr |
| Mar2021 | ₹2,591 Cr |
How is Total Current Liabilities of PIRAMAL PHARMA Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹3,766 Cr | -13.80 | |
| Mar2024 | ₹4,369 Cr | 13.46 | |
| Mar2023 | ₹3,851 Cr | 23.51 | |
| Mar2022 | ₹3,118 Cr | 20.35 | |
| Mar2021 | ₹2,591 Cr | - | |
Compare Total Current Liabilities of peers of PIRAMAL PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| PIRAMAL PHARMA | ₹23,261.0 Cr | -4.9% | 17.8% | -17.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹457,121.0 Cr | 0.4% | 10.8% | 10.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹181,396.0 Cr | 0.7% | 9.5% | 16.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹148,730.0 Cr | -2.5% | 6% | 36.2% | Stock Analytics | |
| CIPLA | ₹115,241.0 Cr | 9.7% | 16.7% | -4.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹111,126.0 Cr | 4.5% | 9.7% | 9% | Stock Analytics | |
PIRAMAL PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| PIRAMAL PHARMA | -4.9% |
17.8% |
-17.7% |
| SENSEX | -0.9% |
-3.6% |
-8.6% |
You may also like the below Video Courses